We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.05 | 3.79% | 1.37 | 1.342 | 1.398 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 1.35 | 1.322 | 1.35 | 3,583,905 | 16:35:10 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Finance Services | 0 | -6.69M | -0.0050 | -2.64 | 17.71M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 27/6/2024 | 16:39 | UK RNS | Hemogenyx Pharmaceuticals PLC Result of Annual General Meeting |
| 17/6/2024 | 19:55 | ALNC |  IN BRIEF: Hemogenyx Pharmaceuticals updates on leukemia treatment |
| 17/6/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Operations Update |
| 03/6/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Posting of Annual Report & Notice of AGM |
| 25/4/2024 | 12:19 | ALNC | EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout |
| 25/4/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Final Results |
| 28/3/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Total Voting Rights |
| 29/2/2024 | 14:04 | ALNC | Hemogenyx Pharmaceuticals raises money for leukaemia treatment |
| 29/2/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 million |
| 16/2/2024 | 11:27 | ALNC | Hemogenyx shares rise on potential for CBR to treat brain diseases |
1 Year Hemogenyx Pharmaceuticals Chart |
Intraday Hemogenyx Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
